By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company MabCure, Inc.

MabCure, Inc. (MBCI)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 20 Aug 2025, 20:00
$7.03K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

MBCI Stock Price Chart

Explore MabCure, Inc. interactive price chart. Choose custom timeframes to analyze MBCI price movements and trends.

MBCI Company Profile

Discover essential business fundamentals and corporate details for MabCure, Inc. (MBCI) to support your stock research and investment decisions.

Sector

Energy

Industry

Solar

IPO Date

5 Dec 2007

Employees

3.00

Website

CEO

Jehu Thomas Degerold Hand

Description

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

MBCI Financial Timeline

Browse a chronological timeline of MabCure, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

MBCI Stock Performance

Access detailed MBCI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run